Masihur Rehman Ajmal1, Monika Yaccha2, Mohammed Azharuddin Malik3, M U Rabbani1, Ibne Ahmad4, Najmul Isalm5, Nasar Abdali6. 1. Professor, Department of Medicine, J.N. Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh 202001, India. 2. Senior Resident, Department of Nephrology, SGPGI, Lucknow, India. 3. Assistant Professor, Department of Medicine, J.N. Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh 202001, India. Electronic address: malikazharuddin@gmail.com. 4. Professor, Department of Radiodiagnosis, J.N. Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh 202001, India. 5. Professor, Department of Biochemistry, J.N. Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh 202001, India. 6. Senior Resident, Department of Medicine, J.N. Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh 202001, India.
Abstract
BACKGROUND: There is increasing recognition of association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD). Metabolic syndrome is common in both NAFLD and cardiovascular diseases. Our study is designed to investigate the association of NAFLD with cardiovascular disease. METHODS: It's a cross-sectional study which included 104 patients of coronary artery disease and hypertensive heart disease. Those patients having secondary causes of steatosis were excluded. Complete cardiovascular evaluation which included assessment of metabolic syndrome, routine biochemistries, viral markers, Ultrasonography (USG) abdomen, hs-CRP and TNF-α levels were obtained for all patients. RESULTS: Of all patients with cardiovascular disease, 19.2% (20/104) had essential hypertension with hypertensive heart disease the remaining 80.8% (84/104) patients had ischemic heart disease (IHD). On USG 69.2% (72/104) had NAFLD, these 50% (36/72) had grade 1 NAFLD and the rest grade 2 NAFLD. The hs-CRP levels and TNF-α were significantly higher in patients with NAFLD (p-value <0.001) and within patients with NAFLD the levels were higher in patients with grade 2 NAFLD. Also, binary logistic regression showed that high body-mass index (BMI), raised serum triglyceride levels, increased waist circumference and hypertension were significantly associated with the presence of NAFLD. CONCLUSION: Our data indicates that NALD is highly prevalent in patients of cardiovascular disease (69.2%) and is significantly associated with metabolic syndrome and its individual components. The levels of hs-CRP and TNF-α were significantly higher in patients with NAFLD and showed an increasing trend with the severity of fatty liver.
BACKGROUND: There is increasing recognition of association of nonalcoholic fatty liver disease (NAFLD) with cardiovascular disease (CVD). Metabolic syndrome is common in both NAFLD and cardiovascular diseases. Our study is designed to investigate the association of NAFLD with cardiovascular disease. METHODS: It's a cross-sectional study which included 104 patients of coronary artery disease and hypertensive heart disease. Those patients having secondary causes of steatosis were excluded. Complete cardiovascular evaluation which included assessment of metabolic syndrome, routine biochemistries, viral markers, Ultrasonography (USG) abdomen, hs-CRP and TNF-α levels were obtained for all patients. RESULTS: Of all patients with cardiovascular disease, 19.2% (20/104) had essential hypertension with hypertensive heart disease the remaining 80.8% (84/104) patients had ischemic heart disease (IHD). On USG 69.2% (72/104) had NAFLD, these 50% (36/72) had grade 1 NAFLD and the rest grade 2 NAFLD. The hs-CRP levels and TNF-α were significantly higher in patients with NAFLD (p-value <0.001) and within patients with NAFLD the levels were higher in patients with grade 2 NAFLD. Also, binary logistic regression showed that high body-mass index (BMI), raised serum triglyceride levels, increased waist circumference and hypertension were significantly associated with the presence of NAFLD. CONCLUSION: Our data indicates that NALD is highly prevalent in patients of cardiovascular disease (69.2%) and is significantly associated with metabolic syndrome and its individual components. The levels of hs-CRP and TNF-α were significantly higher in patients with NAFLD and showed an increasing trend with the severity of fatty liver.
Authors: Ariel E Feldstein; Nathan W Werneburg; Ali Canbay; Maria Eugenia Guicciardi; Steven F Bronk; Robert Rydzewski; Laurence J Burgart; Gregory J Gores Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo; Christopher P Day Journal: Obesity (Silver Spring) Date: 2008-03-27 Impact factor: 5.002
Authors: Deepak N Amarapurkar; Estsuko Hashimoto; Laurentius A Lesmana; José D Sollano; Pei-Jer Chen; Khean-Lee Goh Journal: J Gastroenterol Hepatol Date: 2007-06 Impact factor: 4.029
Authors: Mavidi Sunil Kumar; Akanksha Singh; Ashok Kumar Jaryal; Piyush Ranjan; K K Deepak; Sanjay Sharma; R Lakshmy; R M Pandey; Naval K Vikram Journal: Int J Hepatol Date: 2016-12-08
Authors: Sumitro Kosasih; Wong Zhi Qin; Rafiz Abdul Rani; Nazefah Abd Hamid; Ngiu Chai Soon; Shamsul Azhar Shah; Yazmin Yaakob; Raja Affendi Raja Ali Journal: Int J Hepatol Date: 2018-09-27